Neural circuits are topographically organized into functional compartments with specific molecular profiles. Here, we provide the practical and technical steps for revealing global brain topography using a versatile wholemount immunohistochemical staining approach. We demonstrate the utility of the method using the well-understood cytoarchitecture and circuitry of cerebellum.
The repeated and well-understood cellular architecture of the cerebellum make it an ideal model system for exploring brain topography. Underlying its relatively uniform cytoarchitecture is a complex array of parasagittal domains of gene and protein expression. The molecular compartmentalization of the cerebellum is mirrored by the anatomical and functional organization of afferent fibers. To fully appreciate the complexity of cerebellar organization we previously refined a wholemount staining approach for high throughput analysis of patterning defects in the mouse cerebellum. This protocol describes in detail the reagents, tools, and practical steps that are useful to successfully reveal protein expression patterns in the adult mouse cerebellum by using wholemount immunostaining. The steps highlighted here demonstrate the utility of this method using the expression of zebrinII/aldolaseC as an example of how the fine topography of the brain can be revealed in its native three-dimensional conformation. Also described are adaptations to the protocol that allow for the visualization of protein expression in afferent projections and large cerebella for comparative studies of molecular topography. To illustrate these applications, data from afferent staining of the rat cerebellum are included.
1. Animal Perfusion and Cerebellum Dissection
2. Processing the Tissue for Wholemount Staining
Because the wholemount staining approach takes longer than immunohistochemical staining of tissue sections, it is helpful to plan the timeline for each of the experiments as shown in the example calendar provided (Table 2). Before starting, there are several key things to keep in mind. 1) The microtubes containing the tissue should be rotated on a nutator at all times, except during the freeze/thaw process. 2) Several solutions must be made fresh for each experiment (See Table 3 for solution recipes). 3) Throughout the protocol, when changing solutions, gently pour out the spent solution rather than removing the cerebellum with forceps, to avoid touching the cerebellum. Then, after mixing the new solution in another container, use a pipette to gently add the fresh solution to the tube.
2.1 Day 1:
2.2 Day 2:
2.3 Day 3:
2.4 Day 4-5:
2.5 Day 6:
2.6 Day 7:
2.7
When the optimal staining intensity is reached, stop the reaction by placing the cerebellum in PBS with 0.04% sodium azide. The tissue may be stored long-term in this solution. Sodium azide is a potent inhibitor of bacterial growth but should be avoided until this step as it also inhibits horseradish peroxidase.
2.8 Optional amplification procedure:
follow normal protocol but these steps should be performed in place of steps 2.5b-2.7 above.
3. Imaging the Stained Tissue
Animals
All animal studies were carried out under an approved IACUC animal protocol according to the institutional guidelines at Albert Einstein College of Medicine. Male and female outbred Swiss Webster (Taconic, Albany, NY) mice were maintained in our colony and used for all studies. Euthanized adult rats were kindly provided by Dr. Bryen Jordan (Albert Einstein College of Medicine). All animals were at least one month old.
4. Representative Results
The cerebellum is compartmentalized by molecular expression into four transverse zones: the anterior zone (AZ: ~lobules I-V), the central zone (CZ: ~lobules VI-VII), the posterior zone (PZ: ~lobules VIII-dorsal IX) and the nodular zone (NZ: ~lobules IX ventral and X)5. Each zone contains a unique array of parasagittal stripes1,2,5,6 (Fig. 1). ZebrinII expression in Purkinje cells reveals stripes in the AZ and PZ (Fig. 2) and uniform expression in the CZ and NZ (Fig. 2). The parasagittal organization of Purkinje cells is mirrored by the terminal field topography of afferent fibers. Cocaine- and amphetamine-regulated transcript (CART) peptide is expressed in subsets of climbing fibers (Fig. 3a) that project to stripes of Purkinje cell dendrites in the molecular layer of the cerebellar cortex7 (Fig. 3b). With the appropriate modifications, such as amplification7, the wholemount protocol allows for the visualization of olivocerebellar patterns without the need for a laborious, time consuming reconstructions from staining tissue sections (Fig. 3b).
Figure 1. A. ZebrinII/aldolaseC expression reveals sagittal bands in transverse sections of the cerebellum. Scale bar = 500 μm. B. ZebrinII/aldolaseC is expressed exclusively in Purkinje cell somata and dendrites. Scale bar = 150μm (gl = granular layer; pcl = Purkinje cell layer; ml=molecular layer).
Figure 2. A wholemount cerebellum stained for ZebrinII/aldolaseC showing Purkinje cell stripes in images of the anterior (AZ), central (CZ), and posterior (PZ) zones of the cerebellum. Here we also show an example of the negative consequence of nicking the cerebellum. The resulting artifactual staining is indicated with red asterisks. Scale bar = 1 mm (LS = lobulus simplex; PML = paramedian lobule; COP = copula pyramidis).
Figure 3. A. CART is expressed in climbing fiber terminals in the molecular layer. Scale bar = 100 μm (ml = molecular layer; pcl = Purkinje cell layer; gl = granular layer). B. Wholemount immunohistochemistry of CART expression in the NZ. Scale bar = 2 mm (COP = copula pyramidis; PML = paramedian lobule; PFL = paraflocculus; FL = flocculus).
We have described the technical details required for successful wholemount staining using a versatile immunohistochemical approach for revealing protein expression in the developing and adult brain. By using this approach, complex molecular expression patterns can be analyzed and brain topography appreciated without the need for laborious and time consuming tissue sectioning procedures.
This protocol has been used to reveal the patterned expression of several Purkinje cell proteins in both the adult1,2,8,9 and early postnatal mouse cerebellum10,11,12. Our original studies also demonstrated the utility of the wholemount approach for examining granule cell antigen expression1 and anterogradely traced mossy fibers2, which reside ~250 μm below the pial surface in granular layer. In addition, several studies have made modifications to the original protocol for successful staining of proteins in Purkinje cells1,13 (antigen retrieval) and afferent fibers7,14 (signal amplification; Fig. 2). Moreover, wholemount immunohistochemical staining has also been applied to the cerebella of multiple mammalian4,15 and avian16,17 species, used to map patterned Purkinje cell loss in mouse models of neurodegenerative diseases18,19, and modified to stain heart20, lung21, cranial nerves22 and corneal nerves23. The major departure of the current protocol from previous descriptions of the wholemount method1,2 is that here we provide not only updated details for better success when using the procedure, but also a complete guide for fixing the tissue, dissecting the tissue and an in depth video illustration of the technique.
There are several limitations of wholemount staining. First, only surface patterns are typically visualized without further dissection and staining or without increasing the length of time that the tissue is incubated in antibodies. Further, staining will not reach deep within the cortex if it is hidden due to foliation1,2. However, wholemount stained tissue can be sectioned after processing and restained, with the same antibody or another, to reveal cellular expression profiles deeper within the tissue1,2. Second, the basic wholemount staining protocol is long. We suggest that each experimenter empirically determine the staining efficiency of their antibodies and shorten the post-fixation time, shorten the number and length of washes, and/or shorten the length of incubation in the primary antibodies. With these adjustments the protocol may be completed in a considerably shorter time. Third, for large cerebella the wholemount staining protocol requires large volumes of the antibody solutions, which can be expensive and/or only available in limited quantities. However, it is possible to save the primary antibodies after each run by freezing the solution at -20°C. Each experimenter will have to determine whether their antibody can withstand freezing before it is re-used. We have successfully stained tissue using previously frozen aliquots of zebrinII. Fourth, not all antibodies are compatible with the basic wholemount approach. For example, the antibody commonly used to detect the striped expression of the small heat shock protein, HSP25, requires that the tissue be first processed for antigen retrieval13. Regardless, as for staining tissue sections, traditional methods of troubleshooting antibody-antigen binding have also proven useful for optimizing wholemount staining.
We are currently exploring the possibility of adapting our wholemount protocol for use with fluorescent-tagged secondary antibodies. With the appropriate microscope equipped with the ability to image different colored fluorophores under low-power, one would be able to not only analyze the organization of multiple Purkinje cell maps in the same animal, but also examine the relationship between Purkinje cell stripe patterns and the topography of WGA-Alexa labeled afferent fibers in three-dimensions2,4.7,24. Furthermore, the recent availability of large scale gene expression databases (Allen Brain Atlas, Genepaint, Brain Gene Expression Map) have opened new avenues for merging our high throughput wholemount approach with whole genome analyses for examining the molecular topography of the entire brain.
The authors have nothing to disclose.
RVS is supported by new investigator start-up funds from Albert Einstein College of Medicine of Yeshiva University.
Materials | Function in protocol |
Perfusion pump (Fisher Scientific/13-876-2) | Allows for consistent and slow perfusion. |
Sharp-tip Scissors (FST/14081-08) | General use in perfusion and dissection. |
Blunt-tip Forceps (FST/91100-12) | To stabilize the heart for insertion of the perfusion needle. |
Forceps (FST by Dumont AA/11210-10) | For use during dissection of the brain from the skull and to separate the cerebellum from the rest of the brain. These are essential because they have a slightly rounded tip that helps minimize damage to the cerebellum during dissection. |
Nutator (Fisher Scientific) | Used to keep tissue in motion during incubation periods. |
1.5 mL tube (Sarstedt/Screw Cap Micro Tube) | All steps of the histochemistry protocol take place in these microtubes. The rounded bottom ensures that the cerebellum stays in motion. |
Perforated spoon (FST/10370-17) | Used to keep wholemounts in the microtubes while gently decanting out the spent solution. |
Leica MZ16 FA microscope | Used to examine wholemount staining. |
Leica DFC3000 FX camera | Used to capture wholemount images. |
Table 1.
Example calendar for a typical wholemount experiment | ||||||||
Day 1 | Dent’s fix, room temperature, 8 hrs | Dent’s bleach, 4°C, overnight | ||||||
Day 2 | 100% MeOH, room temperature, 2x, 30 min each | 100% MeOH, Freeze/thaw, 4x, 30 min/15 min |
100% MeOH, -80°C, overnight | |||||
Day 3 | 50% MeOH/50% PBS, room temperature, 60-90 min | 15% MeOH/ 85% PBS, room temperature, 60-90 min | 100% PBS, room temperature, 60-90 min | 10μg/mL Proteinase K in PBS, room temperature, 2-3 min | 100% PBS, room temperature, 3x, 10 min each | PMT, 4°C, overnight | ||
Day 4-5 | PMT + 1° antibody + 5% DMSO, 4°C, 48 hrs | |||||||
Day 6 | PMT, 4°C, 2-3x, 2-3 hrs each | PMT + 2° antibody + 5% DMSO, 4°C, 24 hours (Or begin amplification steps with ABC complex) | ||||||
Day 7 | PMT, 4°C, 2-3x, 2-3 hrs each | PBT, room temperature, 2 hrs | Incubate in fresh DAB in PBS until optimal staining is visualized |
Table 2.
Recipes (*=prepare fresh every time) | |
PBS (phosphate buffered saline) | 0.1M phosphate buffered saline in deionized water. pH 7.2 (Sigma tablets; P4417) |
PFA (Paraformaldehyde) | Made and stored frozen as a 20% solution and then diluted to 4% in PBS for the working solution (Fisher Scientific; T353) |
Dent’s Fixative3* | 4 parts methanol 1 part dimethylsulfoxide (DMSO; Fisher Scientific; D159-4) |
Dent’s Bleach3* | 4 parts methanol 1 part dimethylsulfoxide (DMSO; Fisher Scientific; D159-4) 1 part 30% hydrogen peroxide |
Enzymatic Digestion | 10 μg/ml of Proteinase K (Roche Diagnostics; 03115828001) in PBS. |
PBST | PBS containing: 0.1% Tween-20 (Fisher Scientific, BP337; Triton can also be used in place of Tween-20 in all instances.) |
PMT25* | PBS containing: 2% nonfat skim milk powder (Carnation preferred) 0.1% Tween-20 (Fisher Scientific; BP337) |
PBT25* | PBS containing: 0.2% bovine serum albumin (Sigma; B9001S) 0.1% Tween-20 (Fisher Scientific; BP337) |
DAB* | Dissolve one 10-mg tablet of 3,3-diaminobenzidine (Sigma-Aldrich; D5905) in 40 ml of PBS. Add 10 μl of 30% hydrogen peroxide to initiate reaction). |
ABC Complex Solution | Vectastain kit (Vector laboratories, Inc; PK-4000) |
Table 3.